jtx-2011
mAbexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2016 (NCT02904226)
Timeline
Indications
Mechanism of action
Inducible T-cell costimulator agonist
- Inducible T-cell costimulatorINHIBITOR
ICOS inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4298004 ↗
Also known as
- jtx-2011
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04549025 | Phase 2 | Oct 19, 2020 | Jounce Therapeutics, Inc. |
| NCT04319224 | Phase 1/Phase 2 (Phase 2) | Mar 10, 2020 | Jounce Therapeutics, Inc. |
| NCT03989362 | Phase 2 | Jun 6, 2019 | Jounce Therapeutics, Inc. |
| NCT02904226 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2016 | Jounce Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jounce Therapeutics, Inc. | For profit | 4 | 4 | 1 | 2016 |
1 organizations
Page 1 / 1